Provides patient care coordination, Physician support and skilled nursing assessment and evaluation. Responsible for coordinating Physician’s schedules to include patient care, administrative time and other meetings.
DUTIES AND RESPONSIBILITIES:
Ensures collection of all information necessary for patient assessment at scheduled clinic visits.
Conducts skilled nursing assessments that evaluate physical and emotional status of patients and coordinates appropriate care and follow-up.
Assists Physician with time management to provide timely quality care and follow-up.
Provides clinical data to ensure proper authorizations are obtained to assure accurate billing and reimbursement.
Educates patient and family on disease process and addresses their individual needs and concerns.
Performs other duties as assigned.
Current RN license issued by the Texas State Board of Nurse Examiners.
Must have 1 – 3 years of oncology experience.
Oncology Nurse Certification.
Additional Salary Information: Commensurate with experience.
Internal Number: 4383
About South Texas Oncology & Hematology, PLLC
At the START Center, cancer patients are being treated with some of the most advanced treatments and technology available. The new START Center combines sophisticated treatment modalities and one of the world’s largest and most active Phase I clinical trial programs.The center represents the union of South Texas Oncology and Hematology (STOH) and South Texas Accelerated Research Therapeutics (START).
The physicians of the START Center aim to usher in a new era in cancer treatment, one that combines customized, streamlined cancer treatment with groundbreaking, accelerated drug development efforts. The center houses The physicians of the START Center aim to usher in a new era in cancer treatment.a full spectrum of clinical care for cancer patients, including chemotherapy, state-of- the-art radiation therapy, hormonal therapy and wellness programs. It also is home to an internationally renowned Phase I clinical trials program, where more than 40 promising new drugs are now being tested for the first time in patients.